Innovassynth Technologies (India) Ltd
Innovassynth Technologies (India) Ltd Q1 FY27 Results & Presentation Highlights: Revenue ₹165 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Innovassynth Technologies (India) Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Revenue from operations for quarter ended 30 June 2026: INR 5,599 Lakhs - Revenue from operations for quarter ended 30 June 2025: INR 1,227 Lakhs - Year-on-year revenue growth: Approximately 356% increase (from INR 1,227 Lakhs to INR 5,599 Lakhs) - Volume or sales figures are not explicitly provided. Quarter ended 30 June 2026: - EBITDA: ₹1,497 lakhs (27% margin) - Operating Expenses: ₹4,102 lakhs (used to calculate margin) - PAT: ₹674 lakhs (12% margin) - Year-on-year comparison (vs Q1
From Innovassynth Technologies (India) Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
2 more points management made on revenue & sales performance
Profitability & Margins
See what Innovassynth Technologies (India) Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Life Sciences capacity expansion is underway, aimed at doubling capacity to support growing CRDMO demand (Page 6).
- Capacity expansion is progressing as planned, enabling sustained medium-term growth and profitability improvements (Page 6).
- The company mentions 9 multipurpose manufacturing plants at Khopoli supporting a wide range of chemical processes and production scales (Page 10).
- No specific capex amount or timeline for the capacity expansion is provided in the presentation.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Innovassynth Technologies (India) Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The investor presentation reports an open order book of approximately INR 165 crore as of 30th June 2026 (Page 7).
- It highlights confirmed requirements shared by large global companies, mainly in Life Sciences and Specialty Chemicals (Page 7).
- Major orders are from USA and EU-based companies, with additional orders expected (Page 7).
- The presentation mentions a strong portfolio and custom products supporting the order book (Page 7).
2 more points management made on order book & pipeline
Innovassynth Technologies (India) Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹0 Cr, net loss ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Innovassynth Technologies (India) Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key investor presentation takeaways from Fine
- Chemfab Alkalis Ltd (Q1 FY27)
Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key investor presentation takeaways from Chemfab Alk
- Gujarat Alkalies & Chemicals Ltd (Q1 FY27)
Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q1 FY27 invest
- Amines & Plasticizers Ltd (Q1 FY27)
Q1FY27 Revenue from Operations: ₹150.53 Crores, a 7% year-on-year increase from Q1FY26 (₹140.29 Crores). Key investor presentation takeaways from Amines & Plast
Frequently Asked Questions
What were Innovassynth Technologies (India) Ltd Q1 FY27 results?
Revenue from operations for quarter ended 30 June 2026: INR 5,599 Lakhs - Revenue from operations for quarter ended 30 June 2025: INR 1,227 Lakhs - Year-on-year revenue growth: Approximately 356% increase (from INR 1,227 Lakhs to INR 5,599 Lakhs) - Volume or sales figures are not explicitly provided. Quarter ended 30 June 2026: - EBITDA: ₹1,497 lakhs (27% margin) - Operating Expenses: ₹4,102 lakhs (used to calculate margin) - PAT: ₹674 lakhs (12% margin) - Year-on-year comparison (vs Q1
What is Innovassynth Technologies (India) Ltd share price analysis?
Innovassynth Technologies (India) Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,338 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innovassynth Technologies (India) Ltd planning capital expenditure?
Life Sciences capacity expansion is underway, aimed at doubling capacity to support growing CRDMO demand (Page 6).
Keep Innovassynth Technologies (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.